Where a focused oncology summit earns its place beside partnering events and large congresses, and how to spread one budget across San Diego, London and Boston.
Sponsor ImmunoMark 2027
Our sponsorship team replies within one working day.
Trusted by sponsors from our London 2026 launch edition

Biotech conference sponsorship is easiest to defend at budget review when each event in the plan has a single, measurable job. Brand presence, deal-stage partnering and qualified buyer meetings are different jobs, and they rarely come from the same event.
Most life-science vendors build their year from three event types. The table below sets out what each type buys a sponsor, where the money tends to leak, and where a focused oncology summit series such as ImmunoMark fits. Use it to decide which events carry your 2027 brand spend and which carry your pipeline target.
| Event type | What it buys a sponsor | Where budget leaks | Role in a 2027 plan |
|---|---|---|---|
| Large scientific congress | Category presence and visibility across many therapy areas | Your booth competes with hundreds of others; most passers-by are outside your segment | Brand line. Keep it if your market expects to see you there |
| Partnering event | Deal-stage meetings with BD and licensing teams | The scientists and lab budget-holders who specify tools and services are often not in the room | Licensing and alliance line, not tools or services sales |
| Focused summit (ImmunoMark) | A defined oncology audience, a speaking slot and pre-booked 1:1 meetings with buyers you choose | Smaller headcount, so audience fit has to be checked before you commit | Pipeline line. Judge it on meetings held and opportunities opened |
The same logic applies to pharma conference sponsorship more broadly: a large event is rarely wasted, but it is rarely where a services or tools vendor wins a new oncology programme. The pipeline line is where a smaller, specialist room tends to earn its cost back.
ImmunoMark is an oncology-only summit organised by Convolign Business Consulting, run as two parallel streams: Next-Gen Immuno-Oncology (NGIO) and Biomarkers & Companion Diagnostics. In 2027 it runs three times, which lets you place the spend in the quarter and market that suit your plan.
If you are mapping pharma conferences 2027 by quarter, that gives you two markets in the first quarter, three weeks apart, and a June date in Boston. The London 2026 edition gives you a baseline to plan against:
The audience mix in the prospectus is 55–60% biotech and pharma, 10–15% academic, 5–10% clinicians and about 5% government, regulatory and industry bodies. By seniority, 45–50% are senior leadership (executives, directors and heads). Companies that took part in London 2026 included GSK, Roche, Merck, AstraZeneca, Johnson & Johnson, Bristol Myers Squibb and Incyte.
Run these before any 2027 commitment, ImmunoMark or otherwise. They turn an event line into a number your finance team can test after the event.
Packages are the same at every edition, so you can anchor one edition and test another without relearning the offer. Prices are in the prospectus, which we send on request.
The anchor package for the edition closest to your main market. It combines a talk, a booth and pre-booked meetings, which covers brand and pipeline in one line.
A lower-commitment way to test a second market. No booth to ship, just meetings with delegates your team selects.
When one edition carries most of your target accounts and you want a Day 1 platform plus pre-event reach.
Tell us which editions and buyer roles you are planning for and we will suggest a split.
Get a budget recommendationA sponsorship budget works best as a programme rather than a series of one-off bets. These are the patterns we see vendors plan around.
All spend on the edition where your accounts are. Platinum or Gold, plus a branding item such as the drinks reception, which includes a 5-minute welcome speech.
Gold at your priority edition and Exclusive 1:1 Meetings at the other. San Diego and London sit three weeks apart, so one campaign and one set of materials can cover both.
San Diego in February, London in March and Boston in June. Use the first two to build a meeting list and the June date to follow up with US accounts.
For a wider view of how oncology sponsorship tiers compare, see oncology conference sponsorship. If your budget is booth-first, the exhibitor packages page covers the stand and meeting add-ons. Building a city calendar? Read the sponsor’s guides to pharma conferences in London and medical conferences in San Diego, or our article on how to choose biotech conferences to sponsor.
Full package details by edition: San Diego sponsorship opportunities and London sponsorship opportunities.
What sponsors said
Here is what sponsors told us at our London 2026 launch edition.
We really liked the focus of the event, the topics, the talks, really good opportunity to engage with people, the support we get from you is really great and we appreciate that very much. Based on our experience we would be very interested in also sponsoring the next annual event.

We are always interested in sponsoring interesting conference, based on this years experience, I guess I will manage to get some budget for the next edition.

Conversations I have had are very high level, the footfalls been great and the kind of research going on around is really life changing. We will be very interested in sponsoring the second annual.

My experience here at Immunomark 2026 has been really great. We benefit from very good logistical organisation. Networking sessions were excellent and we consider Immunomark a strategic conference for the coming years.

We got the occasion to discuss customer projects and understand their needs better and how we can help them.

The conference has been great so far with strong interactions at the booth and excellent attendance at our talk. We will definitely think about the next edition.

Quality of the talks were really nice and the attendee list had experts from biotech pharma field. It was great meeting everyone and we look forward to positive outcomes.

The talks have been really interesting so far with a great combination of researchers and clinicians. Moderators encouraged excellent discussions.

Give each event one job. Large congresses usually carry brand presence; a focused summit such as ImmunoMark carries pipeline, judged on meetings held and opportunities opened. Many vendors keep one congress for visibility and move pipeline spend to events where they can pre-book meetings with named buyers.
Yes. San Diego runs on 10–11 February, London on 3–4 March and Boston in June 2027. Packages are the same at every edition, so a common pattern is a Gold or Platinum package at your priority edition and an Exclusive 1:1 Meetings package at a second. Tell us your plan and we will confirm availability.
If meetings are the main goal, the Exclusive 1:1 Meetings package offers 3, 5, 7 or 10 pre-arranged 20-minute meetings with 2–4 passes and no booth. Gold adds a 30-minute talk and a booth with 6 meetings. Prices are in the prospectus, which we send on request.
The London 2026 post-show report: 300+ attendees from 100+ companies, 70% senior decision-makers, 200+ meetings conducted and 15–25 meetings per sponsor. The prospectus also gives the audience split by sector and seniority.
Earlier is better for speaking slots, which are limited per stream, and the Headline package is exclusive to one company per edition. Meeting selection itself happens later: the full delegate list and profiles are sent 10 days before the event.
Sponsor one edition or build a programme across San Diego, London and Boston. We will send the prospectus and availability within one working day.